Works matching United States. Food %26 Drug Administration
Results: 5000
Brief report on the United States Food and Drug Administration Blood Products Advisory Committee recommendations for management of donors and units testing positive for hepatitis B virus DNA.
- Published in:
- Vox Sanguinis, 2006, v. 91, n. 4, p. 331, doi. 10.1111/j.1423-0410.2006.00820.x
- By:
- Publication type:
- Article
United States Food and Drug Administration's authorization of reduced exposure claims for IQOS®: implications for regulation in Latin America.
- Published in:
- Pan American Journal of Public Health / Revista Panamericana de Salud Pública, 2022, v. 46, p. 1, doi. 10.26633/RPSP.2022.155
- By:
- Publication type:
- Article
An evaluation of the Manufacturer And User Facility Device Experience database that inspired the United States Food and Drug Administration's Reclassification of transvaginal mesh.
- Published in:
- Investigative & Clinical Urology, 2018, v. 59, n. 2, p. 126, doi. 10.4111/icu.2018.59.2.126
- By:
- Publication type:
- Article
Drug‐Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.
- Published in:
- Pharmacotherapy, 2018, v. 38, n. 8, p. 785, doi. 10.1002/phar.2152
- By:
- Publication type:
- Article
Pharmacogenomic Biomarker Information in Drug Labels Approved by the United States Food and Drug Administration: Prevalence of Related Drug Use.
- Published in:
- Pharmacotherapy, 2008, v. 28, n. 8, p. 992, doi. 10.1592/phco.28.8.992
- By:
- Publication type:
- Article
基于美国 FAERS 数据库的舒尼替尼相关药品 不良事件信号挖掘与分析.
- Published in:
- Evaluation & Analysis of Drug-Use in Hospitals of China / Zhongguo Yiyuan Yongyao Pingjia yu Fenxi, 2025, v. 25, n. 1, p. 93, doi. 10.14009/j.issn.1672-2124.2025.01.021
- By:
- Publication type:
- Article
基于美国 FAERS 数据库的头孢曲松钠相关药品 不良事件信号挖掘与分析.
- Published in:
- Evaluation & Analysis of Drug-Use in Hospitals of China / Zhongguo Yiyuan Yongyao Pingjia yu Fenxi, 2024, v. 24, n. 11, p. 1389, doi. 10.14009/j.issn.1672-2124.2024.11.021
- By:
- Publication type:
- Article
基于美国 FAERS 数据库的多黏菌素 E 相关药品 不良事件信号挖掘研究.
- Published in:
- Evaluation & Analysis of Drug-Use in Hospitals of China / Zhongguo Yiyuan Yongyao Pingjia yu Fenxi, 2024, v. 24, n. 10, p. 1257, doi. 10.14009/j.issn.1672-2124.2024.10.021
- By:
- Publication type:
- Article
基于美国 FAERS 数据库对替度格鲁肽相关药品 不良事件信号的挖掘与分析.
- Published in:
- Evaluation & Analysis of Drug-Use in Hospitals of China / Zhongguo Yiyuan Yongyao Pingjia yu Fenxi, 2024, v. 24, n. 10, p. 1272, doi. 10.14009/j.issn.1672-2124.2024.10.024
- By:
- Publication type:
- Article
美国食品药品监督管理局《慢性乙型肝炎病毒感染: 治疗药物的 开发行业指南》的更新要点解读 (临床部分).
- Published in:
- Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi, 2022, v. 38, n. 8, p. 1759, doi. 10.3969/j.issn.1001-5256.2022.08.008
- By:
- Publication type:
- Article
Right now, in the right way: U. S. Food and Drug Administration's expanded access program and patient rights.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Type of E-Cigarette Device Used Among Adolescents and Young Adults: Findings From a Pooled Analysis of Eight Studies of 2166 Vapers.
- Published in:
- 2018
- By:
- Publication type:
- journal article
U.S. Food and Drug Administration anticancer drug approval trends from 2016 to 2018 for lung, colorectal, breast, and prostate cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Oncology Drug Development and Approval of Systemic Anticancer Therapy by the U.S. Food and Drug Administration.
- Published in:
- Oncologist, 2013, v. 18, n. 1, p. 104, doi. 10.1634/theoncologist.2012-0235
- By:
- Publication type:
- Article
The Mifepristone Litigation: Untangling the Implications of the Fifth Circuit's Decision for Abortion Access and the U.S. Food and Drug Administration.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 12, p. 1666, doi. 10.7326/M23-2431
- By:
- Publication type:
- Article
U.S. Food and Drug Administration Reasoning in Approval Decisions When Efficacy Evidence Is Borderline, 2013-2018.
- Published in:
- 2021
- By:
- Publication type:
- journal article
An exploratory study evaluated the 30 most commonly reported medications in the United States food and drug administration's adverse event reporting system that are associated with the occurrence of kidney stones.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2024.1377679
- By:
- Publication type:
- Article
Blueprint for Transparency at the U.S. Food and Drug Administration: Recommendations to Advance the Development of Safe and Effective Medical Products.
- Published in:
- Journal of Law, Medicine & Ethics, 2017, v. 45, p. 7, doi. 10.1177/1073110517750615
- By:
- Publication type:
- Article
U.S. Food and Drug Administration Approval Summary: Enzalutamide for the Treatment of Patients With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Oncologist, 2015, v. 20, n. 8, p. 960, doi. 10.1634/theoncologist.2015-0166
- By:
- Publication type:
- Article
The U.S. Food and Drug Administration's Complex Innovative Trial Design Pilot Meeting Program: Progress to date.
- Published in:
- Clinical Trials, 2021, v. 18, n. 6, p. 706, doi. 10.1177/17407745211050580
- By:
- Publication type:
- Article
The U.S. Food and Drug Administration's Evidence-Based Review for Qualified Health Claims: Tomatoes, Lycopene, and Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 14, p. 1074, doi. 10.1093/jnci/djm037
- By:
- Publication type:
- Article
The Role of the U.S. Food and Drug Administration Review Process: Clinical Trial Endpoints in Oncology.
- Published in:
- Oncologist, 2010, v. 15, p. 13, doi. 10.1634/theoncologist.2010-S1-13
- By:
- Publication type:
- Article
U.S. Food and Drug Administration Updates in Nutrition Labeling: What Clinicians Need to Know.
- Published in:
- Annals of Internal Medicine, 2024, v. 177, n. 4, p. 532, doi. 10.7326/M23-3266
- By:
- Publication type:
- Article
A Proposal by the U.S. Food and Drug Administration for Reliance on Single Institutional Review Boards: Proceed Only With Caution.
- Published in:
- Annals of Internal Medicine, 2024, v. 177, n. 3, p. 383, doi. 10.7326/M23-2152
- By:
- Publication type:
- Article
Participant Recruitment From Low- and Middle-Income Countries for Pivotal Trials of Drugs Approved by the U.S. Food and Drug Administration : A Cross-Sectional Analysis.
- Published in:
- Annals of Internal Medicine, 2022, v. 175, n. 12, p. 1675, doi. 10.7326/M22-1857
- By:
- Publication type:
- Article
Key Evidence Supporting Prescription Opioids Approved by the U.S. Food and Drug Administration, 1997 to 2018.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Postmarketing Safety of Vaccines Approved by the U.S. Food and Drug Administration : A Cohort Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The U.S. Food and Drug Administration's Dilemma: How Tightly to Regulate Electronic Cigarettes?
- Published in:
- 2018
- By:
- Publication type:
- journal article
Barriers to Sustainable Food Trade: China’s Exports Food Rejected by the U.S. Food and Drug Administration 2011–2017.
- Published in:
- Sustainability (2071-1050), 2018, v. 10, n. 6, p. 1712, doi. 10.3390/su10061712
- By:
- Publication type:
- Article
Eyes on the Prize: Decoding the Ophthalmic Product Regulations and Intricacies of the U.S. Food and Drug Administration Approval.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2023, v. 39, n. 8, p. 572, doi. 10.1089/jop.2023.0071
- By:
- Publication type:
- Article
Public opinion regarding U.S. Food and Drug Administration approval of aducanumab and potential policy responses: A nationally representative survey.
- Published in:
- Journal of the American Geriatrics Society, 2022, v. 70, n. 6, p. 1685, doi. 10.1111/jgs.17692
- By:
- Publication type:
- Article
Raloxifene examined for breast cancer prevention.
- Published in:
- American Journal of Health-System Pharmacy, 2007, v. 64, n. 17, p. 1774, doi. 10.2146/news070075
- By:
- Publication type:
- Article
Evaluating the Impact of U.S. Food and Drug Administration–Proposed Nutrition Facts Label Changes on Young Adults’ Visual Attention and Purchase Intentions.
- Published in:
- Health Education & Behavior, 2016, v. 43, n. 4, p. 389, doi. 10.1177/1090198116651082
- By:
- Publication type:
- Article
Precision Medicine, Diabetes, and the U.S. Food and Drug Administration.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Assessing the Benefit-Risk for New Drugs.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes Drugs.
- Published in:
- Diabetes Care, 2011, v. 34, p. S101, doi. 10.2337/dc11-s202
- By:
- Publication type:
- Article
Evaluating the accuracy of Chat Generative Pre-trained Transformer version 4 (ChatGPT-4) responses to United States Food and Drug Administration (FDA) frequently asked questions about dental amalgam.
- Published in:
- BMC Oral Health, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12903-024-04358-8
- By:
- Publication type:
- Article
Public Health Takes a Major Hit: Natural Resources Defense Council v. U.S. Food & Drug Administration.
- Published in:
- Ecology Law Quarterly, 2015, v. 42, n. 2, p. 541
- By:
- Publication type:
- Article
QA/QC issues to aid regulatory acceptance of microarray gene expression dataThis article is a US Government work and, as such, is in the public domain in the United States of America.This article is based on a presentation given at âImpact of Genomic Technologies on Regulatory Policies,â 37th Annual Meeting of the Environmental Mutagen Society, September 18, 2006, Vancouver, Canada.The views expressed in this article are those of the authors and not necessarily those of the U.S. Food and Drug Administration.
- Published in:
- Environmental & Molecular Mutagenesis, 2007, v. 48, n. 5, p. 349, doi. 10.1002/em.20293
- By:
- Publication type:
- Article
Risk Assessment of Failures in Generic Drug Development and Approval Procedure under Competitive Generic Drug Therapy and Patent Challenge Exclusivities Provided by the United States Food and Drug Administration.
- Published in:
- Acta Marisiensis. Seria Medica, 2022, v. 68, n. 1, p. 28, doi. 10.2478/amma-2022-0004
- By:
- Publication type:
- Article
Artificial Intelligence and Machine Learning in the Diagnosis and Management of Stroke: A Narrative Review of United States Food and Drug Administration-Approved Technologies.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 11, p. 3755, doi. 10.3390/jcm12113755
- By:
- Publication type:
- Article
Erratum to: The Weber Effect and the United States Food and Drug Administration's Adverse Event Reporting System (FAERS): Analysis of Sixty-Two Drugs Approved from 2006 to 2010.
- Published in:
- Drug Safety, 2014, v. 37, n. 5, p. 381, doi. 10.1007/s40264-014-0159-6
- By:
- Publication type:
- Article
The First 10 Years: Reflecting on Opportunities and Challenges of the Tobacco Products Scientific Advisory Committee of the United States Food and Drug Administration.
- Published in:
- Journal of Legal Medicine, 2020, v. 40, n. 3/4, p. 293, doi. 10.1080/01947648.2020.1868938
- By:
- Publication type:
- Article
Interview with Dr William Slikker Jr., Ph.D., Former Director, National Center for Toxicological Research, U.S. Food and Drug Administration (FDA), USA.
- Published in:
- 2022
- By:
- Publication type:
- Interview
The United States Food and Drug Administration (FDA) regulatory response to combat neglected tropical diseases (NTDs): A review.
- Published in:
- PLoS Neglected Tropical Diseases, 2023, v. 16, n. 1, p. 1, doi. 10.1371/journal.pntd.0011010
- By:
- Publication type:
- Article
How Media Stories in Low- and Middle-Income Countries Discussed the U.S. Food and Drug Administration's Modified Risk Tobacco Product Order for IQOS.
- Published in:
- Nicotine & Tobacco Research, 2023, v. 25, n. 10, p. 1659, doi. 10.1093/ntr/ntad092
- By:
- Publication type:
- Article
An Analysis of Twitter Posts About the U.S. Food and Drug Administration's Menthol Ban.
- Published in:
- Nicotine & Tobacco Research, 2023, v. 25, n. 5, p. 962, doi. 10.1093/ntr/ntac290
- By:
- Publication type:
- Article
The complex pathway to United States Food and Drug Administration approval of Smoflipid.
- Published in:
- JPEN Journal of Parenteral & Enteral Nutrition, 2022, v. 46, n. 4, p. 748, doi. 10.1002/jpen.2262
- Publication type:
- Article
Scientific and Regulatory Policy Committee Points to Consider: Review of the United States Food and Drug Administration (FDA) Guidance on Pathology Peer Review in Nonclinical Toxicology Studies.
- Published in:
- Toxicologic Pathology, 2024, v. 52, n. 2/3, p. 138, doi. 10.1177/01926233241248654
- By:
- Publication type:
- Article
Opioid exposure associated with poppy consumption reported to poison control centers and the U.S. Food and Drug Administration.
- Published in:
- Clinical Toxicology (15563650), 2021, v. 59, n. 8, p. 746, doi. 10.1080/15563650.2020.1866766
- By:
- Publication type:
- Article